Passa al contenuto
Merck
  • Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner.

Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner.

Experimental and therapeutic medicine (2015-02-11)
Jinsheng Xu, Yaling Bai, Jingjing Jin, Junxia Zhang, Shenglei Zhang, Liwen Cui, Huiran Zhang
ABSTRACT

Vascular calcification, a common complication in patients with chronic kidney disease, involves a variety of mechanisms associated with the regulation of calcification-associated factors. Previous clinical studies have indicated that magnesium is involved in the reduction of vascular calcification; however, the mechanism underlying this process remains unknown. The aim of the present study was to investigate the effects of magnesium on β-glycerophosphate (β-GP)-induced calcification and the underlying mechanisms. Primary rat vascular smooth muscle cells (VSMCs) were exposed to 10 mM β-GP in medium with or without the addition of 3 mM magnesium or 2-aminoethoxy-diphenylborate (2-APB; an inhibitor of magnesium transport), for a 14-day period. Calcium deposition and alkaline phosphatase (ALP) activity were measured by Alizarin red staining, quantification of calcium and enzyme-linked immunosorbent assay. The expression levels of core-binding factor α-1 (Cbfα1), matrix Gla protein (MGP) and osteopontin (OPN) were determined by reverse transcription-polymerase chain reaction or western blot analysis, following incubation for 0, 3, 6, 10 and 14 days with the different media. VSMC calcification and ALP activity was reduced significantly in the high-magnesium medium compared with the calcification medium, during the 14-day incubation. The magnesium-induced changes in the VSMCs included a β-GP-induced downregulation of Cbfα1 by day 3 of incubation, an effect that was gradually enhanced over the 14-day period. By contrast, magnesium produced notable increases in MGP and OPN expression levels, with an opposite pattern to that observed in the Cbfα1 expression levels. However, the addition of 2-APB appeared to inhibit the protective effect of magnesium on the VSMCs. Therefore, magnesium was able to effectively reduce β-GP-induced calcification in rat VSMCs by regulating the expression levels of calcification-associated factors in a time-dependent manner.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, meets USP testing specifications
Sigma-Aldrich
Glicina, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Glicina, suitable for electrophoresis, ≥99%
Sigma-Aldrich
Ethyl alcohol, Pure 190 proof, for molecular biology
Sigma-Aldrich
Bromuro di etidio, BioReagent, Molecular Biology, 10 mg/mL in H2O
Sigma-Aldrich
Glicina, BioUltra, Molecular Biology, ≥99.0% (NT)
Sigma-Aldrich
Glicina, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
Sigma-Aldrich
Etanolo, BioUltra, Molecular Biology, ≥99.8%, (absolute alcohol, without additive, A15 o1)
Sigma-Aldrich
2-Aminoethyl diphenylborinate, 97%
Supelco
Etanolo, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Etanolo, standard for GC
Sigma-Aldrich
Etanolo, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Sigma-Aldrich
Cloralio, ≥99%
Sigma-Aldrich
Ethidium bromide, BioReagent, Molecular Biology, powder
Sigma-Aldrich
Bromuro di etidio, BioReagent, Molecular Biology, 500 μg/mL in H2O
SAFC
Glicina
Sigma-Aldrich
Cloralio, crystallized, ≥98.0% (T)
Supelco
Glicina, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glicina, BioXtra, ≥99% (titration)
Sigma-Aldrich
Glicina, ACS reagent, ≥98.5%
Sigma-Aldrich
Cloralio
Sigma-Aldrich
Etanolo, purum, fine spirit, denaturated with 2% 2-butanone, F25 MEK1, ~96% (based on denaturant-free substance)
Sigma-Aldrich
Etanolo
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol
Sigma-Aldrich
Etanolo, tested according to Ph. Eur.
Sigma-Aldrich
Ethidium bromide, ~95% (HPLC)
Sigma-Aldrich
Glicina, 99%, FCC
Sigma-Aldrich
Glicina, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance)
USP
Glicina, United States Pharmacopeia (USP) Reference Standard